发明名称 MEDICINE COMPOSITION
摘要 PROBLEM TO BE SOLVED: To obtain a medicine composition comprising a specific propiophenone derivative as an active ingredient, having excellent urine sugar increasing action based on glucose resorption inhibition in the kidney, showing excellent blood sugar lowering action, forming its aglycon showing extremely weak inhibitory action on a sugar transporting carrier of facilitated diffusion type. SOLUTION: This medicine composition contains a propiophenone derivative of the formula [OH is a (protected) OH; Y is a lower alkyl; Z is a (protected)β-D-glucopyranosyl]propiophenone, preferably 3-(5-benzo[b]furanyl)-2'-(β-D- gluconopyranosyloxy)-6'-hydroxy-4'-methylpropiophenone or its pharmacologically acceptable salt (e.g. sodium salt, etc.), as an active ingredient. The compound of the formula can be made into a preparation by using a medicine carrier (e.g. binder, excipient, etc.). Preferably the daily dose of the compound of the formula is 0.5-15 mg/kg in the case of oral administration and 0.05-3 mg/kg in the case of parenteral administration.
申请公布号 JP2000080041(A) 申请公布日期 2000.03.21
申请号 JP19990059581 申请日期 1999.03.08
申请人 TANABE SEIYAKU CO LTD 发明人 TSUJIHARA KENJI;SAITO KUNIO;MOTOMIYA TERUYA;MATSUMOTO MAMORU;OKU SATORU
分类号 C07H15/203;A61K31/00;A61K31/70;A61K31/7028;A61K31/7034;A61K31/7042;A61K31/7048;A61P3/00;A61P3/06;A61P3/10;A61P13/00;A61P13/12;C07F9/655;C07F9/6574;(IPC1-7):A61K31/704;C07F9/657 主分类号 C07H15/203
代理机构 代理人
主权项
地址